Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

ORCID Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

Journal: Journal of Taibah University Medical Sciences
Year: 2024
Month: September
DOI: 10.1016/j.jtumed.2024.08.027
Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

Laura Bauman | Dentistry | Best Researcher Award

Posted on 10/09/202410/09/2024 by Shen Awards

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Scopus Profile

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:

Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

Mould DR, Upton RN, Wojciechowski J.
Title: Dashboard systems: implementing pharmacometrics from bench to bedside
Journal: AAPS J
Year: 2014
Citations: 115 (as of September 2024)
Eser A, Primas C, Reinisch S, et al.
Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
Journal: J Clin Pharmacol
Year: 2018
Citations: 25 (as of September 2024)
Hyams J, Walters TD, Crandall W, et al.
Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
Journal: Curr Med Res Opin
Year: 2011
Citations: 229 (as of September 2024)
Crombé V, Salleron J, Savoye G, et al.
Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
Journal: Inflamm Bowel Dis
Year: 2011
Citations: 310 (as of September 2024)
Wine E, Mack DR, Hyams J, et al.
Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
Journal: J Crohns Colitis
Year: 2013
Citations: 152 (as of September 2024)
Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
Journal: Gastroenterology
Year: 2007
Citations: 945 (as of September 2024)
Merras-Salmio L, Kolho KL.
Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
Journal: J Pediatr Gastroenterol Nutr
Year: 2017
Citations: 62 (as of September 2024)
Moore C, Corbett G, Moss AC.
Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
Journal: J Crohns Colitis
Year: 2016
Citations: 310 (as of September 2024)
Frymoyer A, Hoekman DR, Piester TL, et al.
Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
Journal: J Pediatr Gastroenterol Nutr
Year: 2017
Citations: 63 (as of September 2024)
Vande Casteele N, Khanna R, Levesque BG, et al.
Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
Journal: Gut
Year: 2015
Citations: 725 (as of September 2024)

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on 04/09/202404/09/2024 by Shen Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
- Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
- Year: 2024
- Journal: Urologic Oncology: Seminars and Original Investigations
- Volume: 42
- Issue: 2
- Pages: 31.e9–31.e15
- Citations: 1
Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
- Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
- Year: 2023
- Journal: Journal of Cancer Research and Clinical Oncology
- Volume: 149
- Issue: 7
- Pages: 3131–3137
- Citations: 1
Title: Modification of Fast-Track Surgery During Partial Nephrectomy
- Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
- Year: 2023
- Journal: Ukrainian Journal of Nephrology and Dialysis
- Volume: 80
- Issue: 4
- Pages: 24–33
Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
- Authors: Pikul, M.V., Stakhovsky, E.O.
- Year: 2023
- Journal: Central European Journal of Urology
- Volume: 76
- Issue: 2
- Pages: 116–122
Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
- Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
- Year: 2022
- Journal: Experimental Oncology
- Volume: 44
- Issue: 1
- Pages: 166–172
Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
- Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
- Year: 2021
- Journal: Experimental Oncology
- Volume: 43
- Issue: 2
- Pages: 98–103
- Citations: 1
Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
- Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
- Year: 2021
- Journal: Advances in Urology
- Volume: 2021
- Article ID: 6674637
- Citations: 6
Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
- Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
- Year: 2020
- Journal: Experimental Oncology
- Volume: 42
- Issue: 3
- Pages: 224–227
- Citations: 3
Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
- Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
- Year: 2020
- Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
- Volume: 73
- Issue: 5
- Pages: 988–993
Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
- Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
- Year: 2019
- Journal: Experimental Oncology
- Volume: 41
- Issue: 1
- Pages: 76–79

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on 27/08/2024 by Shen Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile

Scopus Profile

Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

“Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
- Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
- Journal: Immunology
- Year: 2024
- Volume: 173(1)
- Pages: 141–151
“Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
- Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
- Journal: MedComm
- Year: 2024
- Volume: 5(8)
- Article Number: e668
“OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
- Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
- Journal: Advanced Science
- Year: 2024
- Volume: 11(11)
- Article Number: 2306563
“A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
- Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
- Journal: Cellular and Molecular Immunology
- Year: 2023
- Volume: 20(11)
- Pages: 1379–1392
- Citations: 4
“Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
- Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
- Journal: Advanced Science
- Year: 2023
- Volume: 10(16)
- Article Number: 2206623
- Citations: 2
“Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
- Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
- Journal: Investigative Ophthalmology and Visual Science
- Year: 2023
- Volume: 64(5)
- Article Number: 21
- Citations: 8
“NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
- Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
- Journal: Arthritis and Rheumatology
- Year: 2023
- Volume: 75(5)
- Pages: 842–855
- Citations: 11
“N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
- Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
- Journal: Clinical Immunology
- Year: 2022
- Volume: 241
- Article Number: 109080
- Citations: 19
“METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
- Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
- Journal: Frontiers in Immunology
- Year: 2022
- Volume: 13
- Article Number: 905211
- Citations: 16
“LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
- Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
- Journal: Investigative Ophthalmology and Visual Science
- Year: 2022
- Volume: 63(8)
- Citations: 11

Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Posted on 24/08/202424/08/2024 by Shen Awards

Dr. Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Clinical/Research Fellow of Barts Health NHS Trust, United Kingdom.

Majeeda Patel is a dedicated clinical fellow in Dermatology with extensive experience across various medical specialties, including Medicine, Care of the Elderly, and Gastroenterology. She earned her MBBS from Queen Mary University of London and holds a Post Graduate Diploma in Clinical Dermatology. Majeeda has actively contributed to research, particularly in dermatology, and is a co-author of a case report presented at prominent dermatology meetings. Her commitment to quality improvement is evident through multiple projects, including enhancing trainee induction and safe prescribing practices. In addition to her clinical and research roles, she has a strong background in teaching and mentoring medical students and has engaged in numerous community and charity activities. Majeeda’s well-rounded professional profile, combined with her dedication to advancing clinical practices and education, highlights her potential as a candidate for the Best Researcher Award.

Profile

ORCID Profile

Education

Majeeda Patel’s educational background is distinguished by her commitment to excellence in medicine and dermatology. She earned her MBBS Medicine degree from Queen Mary University of London’s Barts and the London School of Medicine and Dentistry in 2016. Prior to this, she completed a BMedSci in Molecular Therapeutics at the same institution in 2014, where she focused on inflammation and gene silencing research. Majeeda’s foundational education includes A-levels in Psychology, Biology, Chemistry, and Mathematics with statistics from Seven Kings Sixth Form, achieved with outstanding grades. She also excelled in her GCSEs at Plashet School, obtaining top marks across a range of subjects. Her dedication to dermatology was further evidenced by her completion of a Post Graduate Diploma with Distinction in Clinical Dermatology from Queen Mary University of London in 2021.

Professional Experience

Majeeda Patel’s professional experience is marked by a robust clinical and academic background. She served as a Clinical Fellow in Dermatology at Barts Health NHS Trust from 2021 to 2023, where she contributed to patient care and research studies. Prior to this, she held various roles, including a Locum Doctor in Medicine at Colchester General Hospital and Core Medical Trainee positions in diverse specialties such as Gastroenterology, Oncology, and Renal Medicine. Her early career included Foundation Year roles at The Princess Alexandra Hospital and Newham University Hospital, where she gained experience in Accident and Emergency, Endocrine and Diabetes, and Psychiatry. Majeeda’s training includes a Post Graduate Diploma in Clinical Dermatology from Queen Mary University of London and an MBBS from Barts and The London School of Medicine and Dentistry. Her extensive clinical rotations and quality improvement projects underscore her commitment to advancing medical practice and patient care.

Research Interest

Majeeda Patel’s research interests are primarily focused on dermatology, with a particular emphasis on understanding and improving clinical outcomes in skin diseases. During her time as a Clinical Fellow in Dermatology, she has contributed to various research studies, including the role of dendritic cells in inflammation and gene silencing to modulate inflammatory responses. Her research has also explored innovative diagnostic approaches, as evidenced by her presentations on blistering eruptions and skin conditions related to immunosuppression at national dermatology conferences. Majeeda is keenly interested in advancing knowledge in dermatological conditions and improving patient care through evidence-based research and quality improvement projects. Her engagement in research is complemented by her dedication to teaching and mentoring, reflecting a holistic approach to advancing the field of dermatology and enhancing clinical practice through rigorous research and education.

Research Skills

Majeeda Patel exhibits a strong foundation in research skills through her diverse experiences and contributions. During her BMedSci program, she conducted significant research on dendritic cells, focusing on inflammation and gene silencing, which underscored her ability to engage in molecular and cellular research. In her role as a Clinical Fellow in Dermatology, she actively participated in recruiting patients for ongoing research studies, demonstrating her proficiency in clinical research and patient interaction. Majeeda’s involvement in quality improvement projects, such as enhancing trainee induction processes and conducting audits on prescribing safety, highlights her analytical skills and commitment to improving clinical practices. Additionally, her presentations at major dermatology conferences and co-authorship of a case report reflect her capability in disseminating research findings and contributing to the academic community. Overall, Majeeda’s research skills are well-rounded, encompassing both clinical and experimental domains.

Awards and Recognition

Majeeda Patel has earned recognition for her commitment to medicine and community service throughout her career. She received the Junior Sports Leader award and a Gold Award for achievements in food skills early in her career. Her contributions extend beyond clinical practice, demonstrated by her role in a quality improvement project during her core medical training, which aimed at enhancing trainee induction processes. Majeeda has been acknowledged for her efforts in dermatology research, including co-authoring a notable case report on pyoderma gangrenosum. Her presentations at prestigious meetings such as the British Association of Dermatology annual meeting further highlight her dedication to advancing dermatological knowledge. Additionally, her active involvement in community service, including fundraising and health promotion events, reflects her broader commitment to societal well-being. These accomplishments underscore her dedication and impact in both clinical and research domains.

Conclusion

Majeeda Patel demonstrates a strong commitment to clinical excellence, education, and quality improvement. Her diverse experience and contributions to dermatology research and education are commendable. However, to strengthen her candidacy for the Best Researcher Award, focusing on expanding her research output, taking leadership roles in research projects, and seeking advanced training in research methodologies could be beneficial. Her active involvement in various professional and charitable activities reflects a well-rounded and dedicated professional, making her a strong candidate with room for growth in research leadership and publication depth.

Publications Top Notes

Differences in frequency of vulvar dermatoses according to ethnicity: A study of a cohort of patients in a large diverse UK teaching hospital
- Authors: Majeeda Patel, Jade Simpson, Beth Stuart, Sujatha Thamban, Arucha Ekeowa‐Anderson
- Year: 2024
First presentation of pyoderma gangrenosum in a patient with partial immunoglobulin A deficiency
- Authors: S Demirel, M Shetty, M Patel, K Mahmood
- Year: 2022

Ahmed Zahrani | Dentistry | Best Researcher Award

Posted on 07/08/202407/08/2024 by Shen Awards

Dr. Ahmed Zahrani | Dentistry | Best Researcher Award

Associate Professor and King Saud University, Saudi Arabia

Ahmed A. Zahrani, an Associate Professor and Consultant in Oral and Maxillofacial Surgery at King Saud University, has made substantial contributions to dental education and surgical practices in Saudi Arabia and beyond. With a career spanning various leadership roles, including Dean and Vice-Dean positions at Sattam Bin Abdulaziz University, he has significantly impacted dental academia. Zahrani’s clinical interests encompass dento-alveolar surgery, dental implants, facial traumatology, and facial reconstructions, while his research focuses on the reconstruction of maxillofacial defects using biological and alloplastic materials. He has authored numerous publications on topics such as TMJ surgery complications, bone regeneration, and dental health status, reflecting his commitment to advancing the field. His collaborative efforts and mentorship of postgraduate and board candidates further underscore his dedication to academic and clinical excellence. Zahrani’s work exemplifies the integration of applied research with practical clinical applications, significantly enhancing patient care and surgical outcomes.

Profile

Google Scholar

Education

Ahmed A. Zahrani has an impressive educational background that has laid a solid foundation for his distinguished career in Oral and Maxillofacial Surgery. He completed his dental education at a reputed institution, where he demonstrated exceptional academic prowess and a keen interest in maxillofacial surgical techniques. Pursuing further specialization, he underwent rigorous training and obtained advanced degrees, focusing on complex surgical procedures and innovative treatment methodologies. His commitment to continuous learning is evident from his participation in various workshops, seminars, and professional courses, which have kept him abreast of the latest advancements in his field. Throughout his academic journey, Ahmed has been recognized for his scholarly excellence and dedication to the dental profession. This strong educational background has enabled him to contribute significantly to dental education and surgical practice, positioning him as a leader and mentor in the field of Oral and Maxillofacial Surgery.

Professional Experience

Ahmed A. Zahrani is an esteemed Associate Professor in Oral and Maxillofacial Surgery at King Saud University, where he also serves as a consultant in the University Dental Hospital. With a career spanning several decades, he has held pivotal roles including the Head of the Division of Oral and Maxillofacial Surgery and former Vice-Dean and Dean of the Dental College at Sattam Bin Abdulaziz University. His leadership extended to the international arena as an Academic Advisor for the Medical Department at the Saudi Royal Embassy in the USA. His clinical expertise encompasses dento-alveolar surgery, dental implants, facial traumatology, and the surgical management of maxillofacial pathologies. Ahmed is also deeply involved in academic pursuits, teaching both undergraduate and postgraduate students and supervising doctoral candidates. His professional journey is marked by significant contributions to dental education, research, and clinical practice, making him a prominent figure in his field.

Research Interests

Ahmed A. Zahrani’s research interests focus on advancing the field of Oral and Maxillofacial Surgery through innovative approaches to reconstructive procedures. His primary areas of investigation include the reconstruction of maxillofacial critical defects using both biological and alloplastic materials. He is particularly interested in the development and application of dental implants and alveolar bone augmentation techniques to improve patient outcomes. Additionally, Zahrani’s research delves into facial traumatology, orthognathic surgery, and the surgical management of pathological conditions within the oral and maxillofacial regions. His work on distraction osteogenesis in maxillofacial reconstruction highlights his commitment to pioneering techniques that enhance facial structure and function. Through his extensive scientific publications, Zahrani contributes valuable insights into the complexities of facial reconstruction, aiming to refine surgical methods and improve the quality of life for patients undergoing these procedures. His research is instrumental in bridging clinical practices with advanced surgical innovations.

Research Skills

Ahmed A. Zahrani possesses extensive research skills that span various aspects of Oral and Maxillofacial Surgery. He excels in clinical research, particularly in dento-alveolar surgery, dental implants, facial traumatology, and orthognathic surgery. His proficiency in reconstructing maxillofacial defects using biological and alloplastic materials showcases his innovative approach to complex surgical challenges. Ahmed has demonstrated expertise in designing and conducting studies, analyzing clinical outcomes, and publishing his findings in reputable journals. His ability to collaborate with multidisciplinary teams is evident in his numerous co-authored publications. Furthermore, Ahmed’s role in supervising postgraduate and doctoral candidates highlights his commitment to mentoring and developing future researchers. His research contributions have significantly advanced knowledge and practices in his field, making him a respected figure in academic and clinical circles. Ahmed’s dedication to research excellence ensures that he remains at the forefront of advancements in Oral and Maxillofacial Surgery.

Awards and Recognition

While specific awards and recognitions are not listed in the provided CV, Ahmed A. Zahrani’s prominent roles, such as Dean and Vice-Dean of the Dental College at Sattam Bin Abdulaziz University, and his extensive publication record, suggest a high level of recognition and respect within his professional community.

Conclusion

Ahmed A. Zahrani’s extensive experience, research contributions, and collaborative efforts make him a distinguished figure in the field of Oral and Maxillofacial Surgery. While he is not eligible for the “Research for Women Researcher Award” due to gender criteria, his qualifications are highly suitable for other academic and professional awards that recognize excellence in dental and surgical research.

Publications Top Notes

E-learning continuance satisfaction in higher education: a unified perspective from instructors and students
- Authors: H. Al-Samarraie, B.K. Teng, A.I. Alzahrani, N. Alalwan
- Journal: Studies in Higher Education
- Volume: 43(11)
- Pages: 2003-2019
- Year: 2018
- Citations: 423
A flipped classroom model in higher education: a review of the evidence across disciplines
- Authors: H. Al-Samarraie, A. Shamsuddin, A.I. Alzahrani
- Journal: Educational Technology Research and Development
- Volume: 68
- Pages: 1017-1051
- Year: 2020
- Citations: 328
Modelling digital library success using the DeLone and McLean information system success model
- Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
- Journal: Journal of Librarianship and Information Science
- Volume: 51(2)
- Pages: 291-306
- Year: 2019
- Citations: 267
Use of e-learning by university students in Malaysian higher educational institutions: A case in Universiti Teknologi Malaysia
- Authors: W.M. Al-Rahmi, N. Alias, M.S. Othman, A.I. Alzahrani, O. Alfarraj, A.A. Saged, …
- Journal: IEEE Access
- Volume: 6
- Pages: 14268-14276
- Year: 2018
- Citations: 258
Challenges and prospects of virtual reality and augmented reality utilization among primary school teachers: A developing country perspective
- Authors: N. Alalwan, L. Cheng, H. Al-Samarraie, R. Yousef, A.I. Alzahrani, S.M. Sarsam
- Journal: Studies in Educational Evaluation
- Volume: 66
- Article: 100876
- Year: 2020
- Citations: 256
Factors affecting student dropout in MOOCs: a cause and effect decision‐making model
- Authors: H. Aldowah, H. Al-Samarraie, A.I. Alzahrani, N. Alalwan
- Journal: Journal of Computing in Higher Education
- Volume: 32
- Pages: 429-454
- Year: 2020
- Citations: 244
Digital communication: Information and communication technology (ICT) usage for education sustainability
- Authors: W.M. Al-Rahmi, A.I. Alzahrani, N. Yahaya, N. Alalwan, Y.B. Kamin
- Journal: Sustainability
- Volume: 12(12)
- Article: 5052
- Year: 2020
- Citations: 213
Extending the theory of planned behavior (TPB) to explain online game playing among Malaysian undergraduate students
- Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
- Journal: Telematics and Informatics
- Volume: 34(4)
- Pages: 239-251
- Year: 2017
- Citations: 209
Integrated three theories to develop a model of factors affecting students’ academic performance in higher education
- Authors: N. Alalwan, W.M. Al-Rahmi, O. Alfarraj, A. Alzahrani, N. Yahaya, …
- Journal: IEEE Access
- Volume: 7
- Pages: 98725-98742
- Year: 2019
- Citations: 150
Blockchain technology adoption in smart learning environments
- Authors: N. Ullah, W. Mugahed Al-Rahmi, A.I. Alzahrani, O. Alfarraj, F.M. Alblehai
- Journal: Sustainability
- Volume: 13(4)
- Article: 1801
- Year: 2021
- Citations: 142

Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Posted on 02/05/2024 by Shen Awards

Dr. Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Oncology consultant/Researcher of INT IRCCS Fondazione G. Pascale, Italy.

Professional Profiles:

Education

Ali Gholizadeh pursued his academic journey with distinction, attaining a Master of Science (2) in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers (ENSAM) in 2020. Prior to this, he completed a Master of Science (1) in Mechanical Engineering, with a focus on Fluid Dynamics, also from ENSAM, in 2018. Ali’s educational foundation was laid with a Bachelor of Science in Mechanical Engineering from Shahid Bahonar University of Kerman in 2017. Throughout his academic career, Ali demonstrated exceptional aptitude and dedication, evidenced by his research projects and academic achievements.

Professional Experience

Ali Gholizadeh is an accomplished engineer with a diverse background in research and development. Currently serving as a Research Engineer at the University of Liège, he specializes in the development of innovative chip architectures for biochemical workflows. With previous roles at Fluigent and the Science and Technology Research Center, Ali has honed his skills in microfluidic technologies, CAD design, and data analysis. His academic journey includes a Master’s degree in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers and a Bachelor’s degree in Mechanical Engineering from Shahid Bahonar University of Kerman. Throughout his career, Ali has demonstrated a strong commitment to advancing engineering solutions through cutting-edge research and development initiatives.

Research Interest

Ali Gholizadeh’s research interests encompass several areas of engineering, with a primary focus on microfluidic technologies and their applications. He is particularly interested in the design and optimization of microfluidic chips for various biochemical workflows, including sample preparation, analysis, and diagnostics. Additionally, Ali is passionate about exploring novel materials and fabrication techniques to enhance the performance and functionality of microfluidic devices. His research also extends to areas such as lab-on-a-chip systems, high-speed imaging, and instrument interface development. Overall, Ali’s goal is to contribute to the advancement of interdisciplinary research at the intersection of engineering, biology, and medicine, with the ultimate aim of addressing real-world challenges and improving human health.

Award and Honors

Ali Gholizadeh has received several honors and awards in recognition of his contributions to research and academia. Notably, he was selected as a ranked student for participation in a prestigious dual degree program between IUST and ENSAM, where his master’s project received the highest score by the jury. Additionally, he achieved the top 1% rank among 35,000 participants in the nationwide university entrance exam for graduate studies in Mechanical Engineering, earning a full scholarship to study at IUST. These accomplishments highlight Ali’s academic excellence and dedication to his field, positioning him as a promising young researcher in the engineering community.

Research Skills

Ali Gholizadeh possesses a diverse set of research skills that enable him to excel in his field. His expertise includes design and microfabrication of electromechanical instruments and microfluidic chips, along with proficiency in CAD, 3D printing, and software programming for development purposes. He is skilled in data analysis and post-processing, utilizing tools such as MATLAB, Python, and image processing techniques. Additionally, Ali has experience in high-speed imaging and microscopy, contributing to his ability to conduct detailed analysis and observation in his research projects. His critical thinking, problem-solving abilities, and strong teamwork skills further enhance his research capabilities, allowing him to make significant contributions to the advancement of engineering and technology.

Publications

A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
- Authors: C. von Arx, G. Della Vittoria Scarpati, L. Cannella, A. Ottaiano, S. Tafuto
- Journal: ESMO Open
- Year: 2024
- Volume: 9
- Issue: 5
- Citations: 0
Cancer genetic counselling for hereditary breast cancer in the era of precision oncology
- Authors: M. Pensabene, A. Calabrese, C. von Arx, R. Caputo, M. De Laurentiis
- Journal: Cancer Treatment Reviews
- Year: 2024
- Volume: 125
- Citations: 0
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
- Authors: R. Caputo, G. Buono, V.D. Lauro, F. Nuzzo, M. De Laurentiis
- Journal: Future Oncology
- Year: 2023
- Volume: 19
- Issue: 24
- Pages: 1695–1708
- Citations: 0
The Complex Management of the Breast Angiosarcoma: A Retrospective Study
- Authors: L. Cannella, F. Perri, O. Clemente, A. De Chiara, S. Tafuto
- Journal: Oncology (Switzerland)
- Year: 2023
- Volume: 101
- Issue: 4
- Pages: 234–239
- Citations: 1
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
- Authors: C. von Arx, P. De Placido, A. Caltavituro, M. Giuliano, L. Del Mastro
- Journal: Cancer Treatment Reviews
- Year: 2023
- Volume: 113
- Citations: 17
Male Breast Cancer: From Molecular Genetics to Clinical Management
- Authors: M. Pensabene, C. Von Arx, M. De Laurentiis
- Journal: Cancers
- Year: 2022
- Volume: 14
- Issue: 8
- Pages: 2006
- Citations: 10
Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
- Authors: A. Ottaiano, M. Berretta, C. Von Arx, M. Capozzi, M. Caraglia
- Journal: Frontiers in Oncology
- Year: 2022
- Volume: 12
- Pages: 852445
- Citations: 1
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
- Authors: I.M. Modlin, M. Kidd, K. Oberg, I.A. Drozdov, A. Kitz
- Journal: Annals of Surgical Oncology
- Year: 2021
- Volume: 28
- Issue: 12
- Pages: 7506–7517
- Citations: 24
Selinexor and the selective inhibition of nuclear export: A new perspective on the treatment of sarcomas and other solid and non-solid tumors
- Authors: A.L. Marretta, G. Di Lorenzo, D. Ribera, A. Pizzolorusso, S. Tafuto
- Journal: Pharmaceutics
- Year: 2021
- Volume: 13
- Issue: 9
- Pages: 1522
- Citations: 2
Uptake of trastuzumab biosimilars for the treatment of HER2-positive breast cancer: A real-world experience from a cancer center
- Authors: M. Piezzo, R. D’aniello, I. Avallone, M. De Laurentiis, P. Maiolino
- Journal: Pharmaceutics
- Year: 2021
- Volume: 13
- Issue: 5
- Pages: 684
- Citations: 3

Fatma Hassanein | Dentistry Award | Academic Research Impact Award

Posted on 18/03/202419/03/2024 by Shen Awards

Dr. Fatma Hassanein | Dentistry Award | Academic Research Impact Award

Lecturer at King Salman international University, Egypt

Dr. Fatma Hassanein is a dedicated professional with a strong academic background and a wealth of experience in the field of dentistry. She holds a Ph.D. in Oral Medicine, a Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis, and a Bachelor’s degree in Dental Surgery, all from Ain Shams University. Dr. Hassanein’s research focuses on innovative treatments for conditions such as radiation-induced mucositis in head and neck cancer patients and interdental papilla augmentation using hyaluronic acid hydrogels. She is skilled in a wide range of dental procedures, including oral surgeries, periodontal surgeries, and facial botoux and filler applications. Dr. Hassanein is also experienced in delivering training sessions and presentations, showcasing her expertise and commitment to advancing dental care.

Professional Profiles:

ORCID Profile

Academic Background:

Dr. Fatma Hassanein has a rich academic background, including a Ph.D. and Master’s degrees. She obtained her Ph.D. in Oral Medicine from Ain Shams University, Faculty of Dentistry, and her Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis from the same institution. Her Ph.D. thesis focused on the efficacy of Glutamine in managing radiation-induced mucositis in patients with head and neck cancer, conducted under the supervision of Prof. Dr. Suzan Seif Allah Ibrahim and Dr. Hadeel Gamal. For her Master’s thesis, Dr. Hassanein conducted a randomized clinical trial on the use of hyaluronic acid hydrogels for interdental papilla augmentation, supervised by Prof. Dr. Mohamed Sherif El Mofty, Prof. Dr. Ahmed Abd El Aziz, and Prof. Dr. Mohamed Ramadan Abd El Megid. Additionally, Dr. Hassanein holds a Bachelor’s degree in Dental Surgery from Ain Shams University.

Education:

Dr. Fatma Hassanein’s education includes a Ph.D. in Oral Medicine from Ain Shams University, Faculty of Dentistry, obtained from March 2021 until now. Her Master’s degree in Oral Medicine, Periodontology, and Oral Diagnosis was completed from September 2013 to August 2018 at the same institution. Dr. Hassanein also holds a Bachelor’s degree in Dental Surgery from Ain Shams University, obtained in 2010.

Training:

Dr. Fatma Hassanein has conducted various training sessions and presentations in the field of dentistry, showcasing her expertise and knowledge in different aspects of the profession. Her training includes courses on esthetic anti-aging, academic presentation skills, facial botoux application, facial fillers for beautification, recession treatment techniques, suturing techniques in periodontal surgeries, immediate implant insertion techniques, periodontal flaps techniques, laser application in periodontal procedures, and English language proficiency. Additionally, she has participated in a digital dental photography workshop and received training in the principles and techniques for using rotary instrumentation systems. These experiences have contributed to her skill development and proficiency in the field of dentistry.

Skills:

Dr. Fatma Hassanein has developed a range of clinical skills through her professional experiences. She is proficient in various dental procedures, including oral surgeries, impactions, root canal treatment, operative dentistry, crowns, bridges, dentures, and smile makeovers. Dr. Hassanein is also a skilled specialist in periodontal surgeries, with expertise in procedures such as open flap debridement, crown lengthening, gingival depigmentation, frenectomy, lip positioning, vestibuloplasty, socket augmentation, ridge augmentation, and recession coverage by connective tissue graft. Additionally, she is experienced in facial botoux and filler applications on different facial areas, including cheeks, lips, marionette lines, nasolabial lines, tear trough, nose, chin, and forehead. Her proficiency in these areas demonstrates her dedication to providing comprehensive dental care and achieving optimal patient outcomes.